AR102048A1 - Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina - Google Patents
Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furinaInfo
- Publication number
- AR102048A1 AR102048A1 ARP150102587A ARP150102587A AR102048A1 AR 102048 A1 AR102048 A1 AR 102048A1 AR P150102587 A ARP150102587 A AR P150102587A AR P150102587 A ARP150102587 A AR P150102587A AR 102048 A1 AR102048 A1 AR 102048A1
- Authority
- AR
- Argentina
- Prior art keywords
- factor
- furina
- secretion
- expression system
- functional
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 108010014173 Factor X Proteins 0.000 abstract 2
- 102000004961 Furin Human genes 0.000 abstract 2
- 108090001126 Furin Proteins 0.000 abstract 2
- 239000012228 culture supernatant Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21075—Furin (3.4.21.75)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462036438P | 2014-08-12 | 2014-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102048A1 true AR102048A1 (es) | 2017-02-01 |
Family
ID=54035298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102587A AR102048A1 (es) | 2014-08-12 | 2015-08-11 | Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9873892B2 (enExample) |
| EP (1) | EP3180427B1 (enExample) |
| JP (1) | JP6793114B2 (enExample) |
| CN (1) | CN107002041B (enExample) |
| AR (1) | AR102048A1 (enExample) |
| AU (1) | AU2015301726B2 (enExample) |
| CA (1) | CA2958056C (enExample) |
| EA (1) | EA035444B1 (enExample) |
| ES (1) | ES2742724T3 (enExample) |
| IL (1) | IL250530B (enExample) |
| MX (1) | MX377236B (enExample) |
| NZ (1) | NZ729729A (enExample) |
| TW (1) | TWI666319B (enExample) |
| WO (1) | WO2016025615A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US11299533B2 (en) | 2017-06-23 | 2022-04-12 | Takeda Pharmaceutical Company Limited | Purification of factor VIII subspecies |
| WO2020257942A1 (en) * | 2019-06-28 | 2020-12-30 | Peel Sean A F | A method for increasing yields and the specific activity of certain recombinant proteins in mammalian cells by co-expressing full-length furin |
| GB202018320D0 (en) * | 2020-11-20 | 2021-01-06 | Univ Newcastle | Methods of producing recombinant complement proteins |
| CN115298204B (zh) * | 2022-01-25 | 2023-04-25 | 青岛万明赛伯药业有限公司 | proNGF突变体及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2109336T3 (es) | 1990-11-26 | 1998-01-16 | Genetics Inst | Expresion de pace en celulas huesped y metodos de utilizacion de la misma. |
| AT404838B (de) | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
| JPH09295945A (ja) * | 1996-04-30 | 1997-11-18 | Hoechst Yakuhin Kogyo Kk | 成熟型骨誘導因子の製造方法 |
| US5876923A (en) | 1996-07-26 | 1999-03-02 | Arch Development Corporation | Herpes simplex virus ICP4 as an inhibitor of apoptosis |
| EP2292657A1 (en) | 1999-11-12 | 2011-03-09 | Baxter Biotech Technology S.A.R.L. | Reduced side-effect hemoglobin compositions |
| US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
| JP2007502623A (ja) * | 2003-05-09 | 2007-02-15 | リサーチ ディベロップメント ファウンデーション | 膜タンパク質におけるフリンプロテアーゼ開裂部位の挿入およびその使用法 |
| SI1969127T2 (sl) * | 2005-12-21 | 2017-10-30 | Cnj Holdings, Inc | Metoda pridobivanja biološko aktivnih proteinov, odvisnih od vitamina K, z rekombinantnimi metodami |
| PL2152735T3 (pl) * | 2007-05-18 | 2015-08-31 | Baxalta Inc | Sposób wytwarzania dojrzałego VWF z propeptydu |
| EP3521422B1 (en) * | 2007-12-31 | 2021-10-06 | Takeda Pharmaceutical Company Limited | Substantially animal protein-free recombinat furin and methods for producing same |
| CN108530543B (zh) | 2009-02-03 | 2023-06-23 | 阿穆尼克斯制药公司 | 延伸重组多肽和包含该延伸重组多肽的组合物 |
| JP5797837B2 (ja) * | 2011-06-02 | 2015-10-21 | バクスター、インターナショナル、インコーポレイテッド | 組換えフューリン製剤 |
-
2015
- 2015-08-11 AR ARP150102587A patent/AR102048A1/es unknown
- 2015-08-11 TW TW104126066A patent/TWI666319B/zh active
- 2015-08-12 AU AU2015301726A patent/AU2015301726B2/en active Active
- 2015-08-12 WO PCT/US2015/044883 patent/WO2016025615A1/en not_active Ceased
- 2015-08-12 US US14/824,927 patent/US9873892B2/en active Active
- 2015-08-12 NZ NZ729729A patent/NZ729729A/en unknown
- 2015-08-12 MX MX2017001931A patent/MX377236B/es active IP Right Grant
- 2015-08-12 CN CN201580055246.1A patent/CN107002041B/zh active Active
- 2015-08-12 CA CA2958056A patent/CA2958056C/en active Active
- 2015-08-12 JP JP2017507848A patent/JP6793114B2/ja active Active
- 2015-08-12 EP EP15757369.2A patent/EP3180427B1/en active Active
- 2015-08-12 EA EA201790360A patent/EA035444B1/ru not_active IP Right Cessation
- 2015-08-12 ES ES15757369T patent/ES2742724T3/es active Active
-
2017
- 2017-02-09 IL IL250530A patent/IL250530B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| TW201625791A (zh) | 2016-07-16 |
| NZ729729A (en) | 2023-07-28 |
| EA035444B1 (ru) | 2020-06-17 |
| EP3180427A1 (en) | 2017-06-21 |
| AU2015301726B2 (en) | 2021-10-21 |
| JP6793114B2 (ja) | 2020-12-09 |
| AU2015301726A1 (en) | 2017-03-16 |
| MX2017001931A (es) | 2017-06-30 |
| CN107002041B (zh) | 2021-06-29 |
| ES2742724T3 (es) | 2020-02-17 |
| WO2016025615A1 (en) | 2016-02-18 |
| US9873892B2 (en) | 2018-01-23 |
| CA2958056C (en) | 2023-07-04 |
| MX377236B (es) | 2025-03-07 |
| TWI666319B (zh) | 2019-07-21 |
| US20160046957A1 (en) | 2016-02-18 |
| IL250530A0 (en) | 2017-03-30 |
| EA201790360A1 (ru) | 2017-06-30 |
| CA2958056A1 (en) | 2016-02-18 |
| JP2017524366A (ja) | 2017-08-31 |
| CN107002041A (zh) | 2017-08-01 |
| EP3180427B1 (en) | 2019-05-22 |
| IL250530B (en) | 2020-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021004479A (es) | Agentes biologicos y su uso en plantas. | |
| IL249828A0 (en) | Limbal stem cells of cultured mammals, methods of their creation and uses thereof | |
| NZ733055A (en) | Anti-c10orf54 antibodies and uses thereof | |
| MX2020000621A (es) | Composiciones para usarse en inmunomodulacion. | |
| SG10201810150UA (en) | Compositions and methods for enhanced gene expression in cone cells | |
| MX2016014235A (es) | Biosintesis microbiana de ergotioneina. | |
| CL2017001227A1 (es) | Ganado lechero híbrido y sistemas para maximizar la ventaja híbrida. | |
| MX363690B (es) | Expansión de celulas madre adultas in vitro. | |
| MX2016013950A (es) | Metodo para producir l-aminoacidos utilizando una bacteria alcalifilica. | |
| AR090319A1 (es) | Biorrefineria integrada | |
| SG11201804485XA (en) | Molded body and production method therefor | |
| FI20140266A7 (fi) | Menetelmä ja laite nanopartikkeleiden valmistamiseksi | |
| MY193650A (en) | Extracellular matrix compositions | |
| MX2016004802A (es) | Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso. | |
| AR102048A1 (es) | Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina | |
| MX2023014907A (es) | Forma solida de (-)-ambrox formada por una biconversion de homofarnesol en presencia de un biocatalizador. | |
| RU2013125729A (ru) | Способ повышения продуктивности крупного рогатого скота | |
| MX2022000516A (es) | Metodos relacionados con celulas pluripotentes. | |
| MY184391A (en) | Microorganism having improved intracellular energy level and method for producing l-amino acid using same | |
| MY168066A (en) | Cigarette Production Method, Cigarette, and Double Cigarette | |
| AR099810A1 (es) | Microorganismos que producen aminoácidos l y proceso para producir aminoácidos l utilizándolos | |
| EP3194573A4 (en) | Mammalian pluripotent stem cells, methods for their production, and uses thereof | |
| MX2017008289A (es) | Metodos para aumentar la estabilidad de la produccion de compuestos en celulas huesped microbianas. | |
| MX2017010670A (es) | Alimento en forma de gel para lechoncillos, metodo para manufacturar el mismo y uso. | |
| PH12019501325A1 (en) | Methods of producing phytoene |